Picture of Somalogic logo

SLGC — Somalogic News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Somalogic Inc expected to post a loss of 21 cents a share - Earnings Preview

* Somalogic Inc  SLGC.OQ   SLGC.O  is expected to show a
fall in
quarterly revenue when it reports  results on March 28. 
    * The New York City-based  company is expected to report  a
28.0% decrease in revenue to $16.55 million from $22.99 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Somalogic Inc is
for a
loss of 21 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Somalogic
Inc is
$7​, above​ its last closing price of $2.33. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.20       -0.20      -0.18     Beat    8.5
 Jun. 30 2022  -0.20       -0.18      -0.13     Beat    26.4
 Mar. 31 2022  -0.16       -0.16      -0.02     Beat    87.3​
 Dec. 31 2021  -0.11       -0.13      -0.13     Met     -2
 ​​                                                     
                                                        ​
 This summary was machine generated March 24 at 21:41 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Somalogic

See all news